HealthEquity, Inc. (HQY) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $96.31 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 9, 2026 | Sean Dodge | BMO Capital | $105.00 | +9.0% |
| Feb 18, 2026 | Peter Warendorf | Barclays | $110.00 | +14.2% |
| Jan 8, 2026 | Scott Schoenhaus | KeyBanc | $125.00 | +29.8% |
| Dec 8, 2025 | Peter Warendorf | Barclays | $118.00 | +22.5% |
| Oct 8, 2025 | Scott Schoenhaus | KeyBanc | $120.00 | +24.6% |
| Sep 3, 2025 | Glen Santangelo | Jefferies | $134.00 | +39.1% |
| Aug 28, 2025 | Daniel Perlin | RBC Capital | $109.00 | +13.2% |
| Mar 25, 2025 | Strong Buy | Raymond James | $115.00 | +19.4% |
| Dec 10, 2024 | Alexander Paris | Barrington | $112.00 | +16.3% |
| Sep 4, 2024 | George Hill | Deutsche Bank | $103.00 | +7.0% |
| Jun 20, 2024 | Stan Berenshteyn | Wells Fargo | $110.00 | +14.2% |
| Jun 4, 2024 | Scott Schoenhaus | KeyBanc | $100.00 | +3.8% |
| Jun 4, 2024 | Mark Marcon | Robert W. Baird | $104.00 | +8.0% |
| Jun 3, 2024 | Alexander Paris | Barrington | $100.00 | +3.8% |
| May 7, 2024 | Stan Berenshteyn | Wells Fargo | $105.00 | +9.0% |
| Apr 4, 2024 | Constantine Davides | JMP Securities | $101.00 | +4.9% |
| Mar 28, 2024 | Glen Santangelo | Jefferies | $95.00 | -1.4% |
| Mar 20, 2024 | Stephanie Davis | Barclays | $104.00 | +8.0% |
| Mar 20, 2024 | Sean Dodge | RBC Capital | $92.00 | -4.5% |
| Sep 21, 2023 | Mark Marcon | Robert W. Baird | $87.00 | -9.7% |
Top Analysts Covering HQY
HQY vs Sector & Market
| Metric | HQY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 9 | 8 | 18 |
| Target Upside | +19.6% | +16187.2% | +19.5% |
| P/E Ratio | 36.07 | 3.75 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-10-31 | $341M | $346M | $350M | 5 |
| 2027-01-31 | $361M | $366M | $370M | 5 |
| 2027-04-30 | $379M | $384M | $389M | 5 |
| 2027-07-31 | $372M | $377M | $382M | 5 |
| 2027-10-31 | $369M | $374M | $378M | 5 |
| 2028-01-31 | $387M | $392M | $396M | 4 |
| 2029-01-31 | $1.60B | $1.62B | $1.64B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-10-31 | $1.14 | $1.16 | $1.18 | 4 |
| 2027-01-31 | $1.14 | $1.16 | $1.18 | 4 |
| 2027-04-30 | $1.29 | $1.31 | $1.33 | 4 |
| 2027-07-31 | $1.35 | $1.38 | $1.40 | 4 |
| 2027-10-31 | $1.30 | $1.33 | $1.34 | 4 |
| 2028-01-31 | $1.30 | $1.32 | $1.34 | 5 |
| 2029-01-31 | $6.10 | $6.20 | $6.32 | 4 |
Frequently Asked Questions
What is the analyst consensus for HQY?
The consensus among 9 analysts covering HealthEquity, Inc. (HQY) is Buy with an average price target of $107.43.
What is the highest price target for HQY?
The highest price target for HQY is $134.00, set by Glen Santangelo at Jefferies on 2025-09-03.
What is the lowest price target for HQY?
The lowest price target for HQY is $70.00, set by Charles Peters at Raymond James on 2021-12-14.
How many analysts cover HQY?
9 analysts have issued ratings for HealthEquity, Inc. in the past 12 months.
Is HQY a buy or sell right now?
Based on 9 analyst ratings, HQY has a consensus rating of Buy (2.00/5) with a +19.6% upside to the consensus target of $107.43.
What are the earnings estimates for HQY?
Analysts estimate HQY will report EPS of $1.16 for the period ending 2026-10-31, with revenue estimated at $346M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.